Literature DB >> 16641462

Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.

Jing-Jou Yan1, Po-Ren Hsueh, Jang-Jih Lu, Feng-Yee Chang, Jainn-Ming Shyr, Jen-Hsien Wan, Yung-Ching Liu, Yin-Ching Chuang, Yi-Chueh Yang, Shih-Ming Tsao, Hsiu-Hung Wu, Li-Shin Wang, Tsuey-Pin Lin, Hsiu-Mei Wu, Hung-Mo Chen, Jiunn-Jong Wu.   

Abstract

Production of extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes was investigated among 291 Escherichia coli and 282 Klebsiella pneumoniae isolates that showed decreased susceptibilities to extended-spectrum cephalosporins from seven Taiwanese medical centers. CTX-M-type and SHV-type enzymes were the most prevalent extended-spectrum beta-lactamases. CMY-2-like and DHA-1-like beta-lactamases were the most prevalent AmpC-type enzymes.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16641462      PMCID： PMC1472213          DOI： 10.1128/AAC.50.5.1861-1864.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Hsiu-Mei Wu; Shu-Huei Tsai; Chin-Luan Chuang; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

Authors:  P L Winokur; A Brueggemann; D L DeSalvo; L Hoffmann; M D Apley; E K Uhlenhopp; M A Pfaller; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

Authors:  M T Nüesch-Inderbinen; H Hächler; F H Kayser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

6.  Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum beta-lactamases.

Authors:  H Vahaboglu; R Ozturk; H Akbal; S Saribas; O Tansel; F Coşkunkan
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

7.  Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae.

Authors:  N Fortineau; L Poirel; P Nordmann
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

8.  Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.

Authors:  J J Yan; W C Ko; S H Tsai; H M Wu; Y T Jin; J J Wu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

9.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

10.  Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan.

Authors:  J J Yan; S M Wu; S H Tsai; J J Wu; I J Su
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191
View more
  17 in total

1.  Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.

Authors:  Ying-Tsong Chen; Tsai-Ling Lauderdale; Tsai-Lien Liao; Yih-Ru Shiau; Hung-Yu Shu; Keh-Ming Wu; Jing-Jou Yan; Ih-Jen Su; Shih-Feng Tsai
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

2.  Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.

Authors:  Lakshmi Chandramohan; Paula A Revell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

3.  Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.

Authors:  N Y Lee; J J Wu; S H Lin; W C Ko; L H Tsai; J J Yan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-18       Impact factor: 3.267

4.  Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.

Authors:  Katsutoshi Yamasaki; Masaru Komatsu; Noriyuki Abe; Saori Fukuda; Yugo Miyamoto; Takeshi Higuchi; Tamotsu Ono; Hisaaki Nishio; Noriyuki Sueyoshi; Kaneyuki Kida; Kaori Satoh; Masahiro Toyokawa; Isao Nishi; Masako Sakamoto; Masahiro Akagi; Isako Nakai; Tomomi Kofuku; Tamaki Orita; Yasunao Wada; Takumi Jikimoto; Shohiro Kinoshita; Kazuaki Miyamoto; Itaru Hirai; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

5.  Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Authors:  Joanna Empel; Anna Baraniak; Elzbieta Literacka; Agnieszka Mrówka; Janusz Fiett; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

6.  Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes.

Authors:  H M Chen; J J Wu; P F Tsai; J Y Wann; J J Yan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-13       Impact factor: 3.267

7.  Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006.

Authors:  L F Mataseje; N Neumann; B Crago; P Baudry; G G Zhanel; M Louie; M R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

Review 8.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

9.  Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.

Authors:  Tsai-Ling Lauderdale; Yih-Ru Shiau; Jui-Fen Lai; Hua-Chien Chen; Chi-Hsin R King
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

10.  CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea.

Authors:  Wonkeun Song; Hyukmin Lee; Kyungwon Lee; Seok Hoon Jeong; Il Kwon Bae; Jae-Seok Kim; Hyo-Sun Kwak
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.